Summary
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Market Segment as follows:
By Type
Urokinase Powder
Urokinase Solution
By Application
Hospital
Clinic
Others
By Company
Wanhua Biochem
NDPharm
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Summary:
Get latest Market Research Reports on Urokinase. Industry analysis & Market Report on Urokinase is a syndicated market report, published as Global and China Urokinase Market Research by Company, Type & Application 2013-2025. It is complete Research Study and Industry Analysis of Urokinase market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.